pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·Sep 10·1 min read
save

Scientists boycott American Diabetes Association after conference expulsions

Sep 10, 2026·read at Fierce Biotech ↗Negative

Following the removal of five scientists from its annual conference in June, members of the American Diabetes Association (ADA) have initiated a boycott of the organization. The protest stems from what participants describe as an unjust expulsion of the researchers during the meeting.

The boycott letter, released on September 9, pledges to halt the review of grants and new articles submitted to the ADA’s flagship journal, Diabetes Care, and to refrain from attending any meetings led by ADA leadership or the board. Hundreds of scientists have signed the open letter, demanding changes in the association’s leadership.

The ADA acknowledged the boycott in a statement, thanking professionals who continue to support its mission and emphasizing its focus on serving the diabetes community. The organization did not comment on any specific actions it might take in response to the boycott.

source

This writeup was produced by pharmadog from original reporting by Fierce Biotech.

Original headline: “Scientists boycott American Diabetes Association as fallout of June conference fracas escalates”

read at Fierce Biotech ↗
739 words · retrieved Sep 11
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
University of Washington
topics
Type 2 Diabetes19CardiologyEndocrinology & MetabolismGLP-1 receptor

related stories

  • Sep 30Superior weight loss, blood sugar control propel Lilly’s amylin-GIP/GLP-1 combo into Phase 3BioSpace
  • Sep 22Novo targets 10-fold jump in oral Wegovy manufacturing capacity by 2030BioSpace
  • Sep 22Novo’s workforce reduction climbs to 13,000 to fuel R&D workBioSpace
  • Sep 22Roche’s Carmot asset normalizes blood sugar, cuts weight in Phase 2 diabetes trialBioSpace
  • Sep 21Novo’s plan to hit $23B in revenue by 2035 leaves investors wantingBioSpace